Results 81 to 90 of about 13,355 (171)

Post-vaccination Mumps. An Infrequent Adverse Event after Wide MMR Vaccination During an Outbreak of Measles in Mexico

Antimicrobial Stewardship & Healthcare Epidemiology
Background: Measles cases increased significantly in the Americas in 2025; the region lost its measles-free status due to the return of endemic transmission in Canada, Mexico, and the U.S., primarily driven by low vaccination rates among unvaccinated or ...
Diana Vilar-Compte, Pamela Graciadiego-Fossas, Ana Cecilia Carbajal-Cesar, Itzel Stella P豥z-Campos, Cyntia Ibanes Guti豲ez, Juan Pablo Ramirez-Hinojosa, Elida Alonso-Tr୳ito, Arturo Galindo-Fraga   +7 more
doaj   +1 more source

Does a correlation exist between delayed vaccination and a decreased vaccine confidence?

Human Vaccines & Immunotherapeutics
Delay in vaccination schedule may result in increased risk of vaccine-preventable outbreaks. Lack of parental confidence in vaccines and sociodemographic factors could be related to those delays. Vaccine Confidence Index (VCI) is an indicator to estimate
Virginia Reverte, Matilde Zornoza-Moreno, Yolanda E. Molina-Salas, Francisco J. Romera-Guirado, María Del Carmen Celdrán-Navarro, Jaime Jesús Pérez-Martín   +5 more
doaj   +1 more source

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol.

PLoS ONE
BackgroundThere are increasing reports of outbreaks of measles in countries that achieved measles elimination using two doses of measles-mumps-rubella (MMR) vaccine, particularly in health care settings. While responses to a third dose of MMR in two-dose
Sumanta Saha, Melanie Millier, Ari Samaranayaka, Liza Edmonds, Emma Best, James Ussher, Andrew Anglemyer, Jennifer Lee, Michael Tatley, Felicity Cutts, Rob van Binnendijk, Peter McIntyre   +11 more
doaj   +1 more source

Intention to vaccinate children against measles: findings from a national survey in the United StatesResearch in context

The Lancet Regional Health. Americas
Summary: Background: The United States is currently experiencing the largest surge of measles cases since 2000, with over 2855 cases reported across the country since January 2025.
Hannah Melchinger, Krutika Kuppalli, Jad A. Elharake, Saad B. Omer, Amyn A. Malik   +4 more
doaj   +1 more source

A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration. [PDF]

Case Rep Dermatol Med, 2023
Nazir HI, Hess AA, Soni A, Potter KA.
europepmc   +1 more source

Lack of Content Uniformity in MMR Vaccine. [PDF]

Contact Context, 2022
Isaacs JT, Almeter PJ, Henderson BS, Hunter AN, Platt TL, Lodder RA.   +5 more
europepmc   +1 more source

Municipality-level measles, mumps, and rubella (MMR) vaccine coverage and deprivation in Brazil: A nationwide ecological study, 2006 to 2020. [PDF]

PLOS Glob Public Health, 2023
Godin A, Pescarini JM, Raja AI, Paixao ES, Ichihara MY, Sato APS, Smeeth L, Barreto ML, Brickley EB.   +8 more
europepmc   +1 more source

MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells

The Journal of Clinical Investigation
The measles, mumps, and rubella (MMR) vaccine protects against all-cause mortality in children, but the immunological mechanisms mediating these effects are poorly known.
Rutger J. Röring, Priya A. Debisarun, Javier Botey-Bataller, Tsz Kin Suen, Özlem Bulut, Gizem Kilic, Valerie A.C.M. Koeken, Andrei Sarlea, Harsh Bahrar, Helga Dijkstra, Heidi Lemmers, Katharina L. Gössling, Nadine Rüchel, Philipp N. Ostermann, Lisa Müller, Heiner Schaal, Ortwin Adams, Arndt Borkhardt, Yavuz Ariyurek, Emile J. de Meijer, Susan L. Kloet, Jaap ten Oever, Katarzyna Placek, Yang Li, Mihai G. Netea   +24 more
doaj   +1 more source

Comparative analysis of immunogenicity of Chinese MMR and MR vaccines following primary vaccination in infants in Gansu Province

Scientific Reports
To systematically compare the immunogenicity differences between measles-mumps-rubella combined (MMR) vaccine and measles-rubella combined (MR) vaccine following first dose vaccination in 8–9-month-old infants, with emphasis on evaluating the response ...
Xue-feng Liang, Xiao-shu Zhang, Jing An, Yu Tang   +3 more
doaj   +1 more source

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy. [PDF]

Front Oncol, 2022
Zhang Y, Gabere M, Taylor MA, Simoes CC, Dumbauld C, Barro O, Tesfay MZ, Graham AL, Ferdous KU, Savenka AV, Chamcheu JC, Washam CL, Alkam D, Gies A, Byrum SD, Conti M, Post SR, Kelly T, Borad MJ, Cannon MJ, Basnakian A, Nagalo BM.   +21 more
europepmc   +1 more source